miRNAs as molecular biomarkers of cancer

References

• Ambros V, Lee RC. Identification of microRNAs and other tiny noncoding RNAs by cDNA cloning. Methods Mol. Biol.265, 131–158 (2004).
   PubMedGoogle Scholar
• Bartel DP. microRNAs: genomics, biogenesis, mechanism, and function. Cell116, 281–297 (2004).
   PubMed Web of Science ®Google Scholar
• He L, Hannon GJ. microRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet.5, 522–531 (2004).
   PubMed Web of Science ®Google Scholar
• Plasterk RH. Micro RNAs in animal development. Cell124, 877–881 (2006).
   PubMed Web of Science ®Google Scholar
• Pasquinelli AE, Hunter S, Bracht J. microRNAs: a developing story. Curr. Opin. Genet. Dev.15, 200–205 (2005).
   PubMed Web of Science ®Google Scholar
• Carleton M, Cleary MA, Linsley PS. microRNAs and cell cycle regulation. Cell Cycle6, 2127–2132 (2007).
   PubMed Web of Science ®Google Scholar
• Lee Y, Kim M, Han J et al. microRNA genes are transcribed by RNA polymerase II. EMBO J.23, 4051–4060 (2004).
   PubMed Web of Science ®Google Scholar
• Cai X, Hagedorn CH, Cullen BR. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA10, 1957–1966 (2004).
   PubMed Web of Science ®Google Scholar
• Cullen BR. Transcription and processing of human microRNA precursors. Mol. Cell16, 861–865 (2004).
   PubMed Web of Science ®Google Scholar
• Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science318, 1931–1934 (2007).
   PubMed Web of Science ®Google Scholar
• Calin GA, Cimmino A, Fabbri M et al. MiR-15a and miR-16–1 cluster functions in human leukemia. Proc. Natl Acad. Sci. USA105, 5166–5171 (2008).
   PubMed Web of Science ®Google Scholar
• Vatolin S, Navaratne K, Weil RJ. A novel method to detect functional microRNA targets. J. Mol. Biol.358, 983–996 (2006).
   PubMed Web of Science ®Google Scholar
• Liu CG, Calin GA, Meloon B et al. An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc. Natl Acad. Sci. USA101, 9740–9744 (2004).
   PubMed Web of Science ®Google Scholar
• Lu J, Getz G, Miska EA et al. microRNA expression profiles classify human cancers. Nature435, 834–838 (2005).
   PubMed Web of Science ®Google Scholar
• Li J, Smyth P, Flavin R et al. Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol.7, 36 (2007).
   PubMed Web of Science ®Google Scholar
• Volinia S, Calin GA, Liu CG et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl Acad. Sci. USA103, 2257–2261 (2006).
   PubMed Web of Science ®Google Scholar
• Yanaihara N, Caplen N, Bowman E et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell9, 189–198 (2006).
   PubMed Web of Science ®Google Scholar
• Johnson SM, Grosshans H, Shingara J et al. RAS is regulated by the let-7 microRNA family. Cell120, 635–647 (2005).
   PubMed Web of Science ®Google Scholar
• Kumar MS, Erkeland SJ, Pester RE et al. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc. Natl Acad. Sci. USA105, 3903–3908 (2008).
   PubMed Web of Science ®Google Scholar
• Iorio MV, Ferracin M, Liu CG et al. microRNA gene expression deregulation in human breast cancer. Cancer Res.65, 7065–7070 (2005).
   PubMed Web of Science ®Google Scholar
• Blenkiron C, Goldstein LD, Thorne NP et al. microRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol.8, R214 (2007).
   PubMed Web of Science ®Google Scholar
• Ueda T, Volinia S, Okumura H et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol.11(2), 136–146 (2010).
   PubMed Web of Science ®Google Scholar
• Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, Visakorpi T. microRNA expression profiling in prostate cancer. Cancer Res.67, 6130–6135 (2007).
   PubMed Web of Science ®Google Scholar
• Ozen M, Creighton CJ, Ozdemir M, Ittmann M. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene27, 1788–1793 (2008).
   PubMed Web of Science ®Google Scholar
• Schaefer A, Jung M, Mollenkopf HJ et al. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int. J. Cancer126, 1166–1176 (2010).
   PubMed Web of Science ®Google Scholar
• Cummins JM, He Y, Leary RJ et al. The colorectal microRNAome. Proc. Natl Acad. Sci. USA103, 3687–3692 (2006).
   PubMed Web of Science ®Google Scholar
• Nagel R, le Sage C, Diosdado B et al. Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res.68, 5795–5802 (2008).
   PubMed Web of Science ®Google Scholar
• Slaby O, Svoboda M, Fabian P et al. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology72, 397–402 (2007).
   PubMed Web of Science ®Google Scholar
• Lanza G, Ferracin M, Gafa R et al. mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol. Cancer6, 54 (2007).
   PubMed Web of Science ®Google Scholar
• Akao Y, Nakagawa Y, Naoe T. microRNA-143 and -145 in colon cancer. DNA Cell Biol.26, 311–320 (2007).
   PubMed Web of Science ®Google Scholar
• Bloomston M, Frankel WL, Petrocca F et al. microRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA297, 1901–1908 (2007).
   PubMed Web of Science ®Google Scholar
• Szafranska AE, Davison TS, John J et al. microRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene26, 4442–4452 (2007).
   PubMed Web of Science ®Google Scholar
• Szafranska AE, Doleshal M, Edmunds HS et al. Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues. Clin. Chem.54, 1716–1724 (2008).
   PubMed Web of Science ®Google Scholar
• Murakami Y, Yasuda T, Saigo K et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene25, 2537–2545 (2006).
   PubMed Web of Science ®Google Scholar
• Ladeiro Y, Couchy G, Balabaud et al. microRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology47, 1955–1963 (2008).
   PubMed Web of Science ®Google Scholar
• Chan JA, Krichevsky AM, Kosik KS. microRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res.65, 6029–6033 (2005).
   PubMed Web of Science ®Google Scholar
• Kefas B, Godlewski J, Comeau L et al. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res.68, 3566–3572 (2008).
   PubMed Web of Science ®Google Scholar
• Ciafre SA, Galardi S, Mangiola A et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophys. Res. Commun.334, 1351–1358 (2005).
   PubMed Web of Science ®Google Scholar
• Novakova J, Slaby O, Vyzula R, Michalek J. microRNA involvement in glioblastoma pathogenesis. Biochem. Biophys. Res. Commun.386, 1–5 (2009).
   PubMed Web of Science ®Google Scholar
• Gillies JK, Lorimer IA. Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. Cell Cycle6, 2005–2009 (2007).
   PubMed Web of Science ®Google Scholar
• Shi L, Cheng Z, Zhang J et al. hsa-miR-181a and hsa-miR-181b function as tumor suppressors in human glioma cells. Brain Res.1236, 185–193 (2008).
   PubMed Web of Science ®Google Scholar
• Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, Ambros V. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol.5, R13 (2004).
   PubMed Web of Science ®Google Scholar
• Silber J, Lim DA, Petritsch C et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med.6, 14 (2008).
   PubMed Web of Science ®Google Scholar
• Gal H, Pandi G, Kanner AA et al. miR-451 and imatinib mesylate inhibit tumor growth of glioblastoma stem cells. Biochem. Biophys. Res. Commun.376, 86–90 (2008).
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl Acad. Sci. USA105, 10513–10518 (2008).
   PubMed Web of Science ®Google Scholar
• Taylor DD, Gercel-Taylor C. microRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol.110, 13–21 (2008).
   PubMed Web of Science ®Google Scholar
• Chen X, Ba Y, Ma L et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res.18, 997–1006 (2008).
   PubMed Web of Science ®Google Scholar
• Weiss GJ, Bemis LT, Nakajima E et al. EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Ann. Oncol.19, 1053–1059 (2008).
   PubMed Web of Science ®Google Scholar
• Yu SL, Chen HY, Chang GC et al. microRNA signature predicts survival and relapse in lung cancer. Cancer Cell13, 48–57 (2008).
   PubMed Web of Science ®Google Scholar
• Garofalo M, Di Leva G, Romano G et al. miR-221 & 222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell16, 498–509 (2009).
   PubMed Web of Science ®Google Scholar
• Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY. microRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res.18, 350–359 (2008).
   PubMed Web of Science ®Google Scholar
• Yan LX, Huang XF, Shao Q et al. microRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA14, 2348–2360 (2008).
   PubMed Web of Science ®Google Scholar
• Zhu S, Si ML, Wu H, Mo YY. microRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem.282, 14328–14336 (2007).
   PubMed Web of Science ®Google Scholar
• Huang Q, Gumireddy K, Schrier M et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat. Cell Biol.10, 202–210 (2008).
   PubMed Web of Science ®Google Scholar
• Diaz LK, Zhou X, Wright ET et al. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma. Clin. Cancer Res.11, 3309–3314 (2005).
   PubMed Web of Science ®Google Scholar
• Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature449, 682–688 (2007).
   PubMed Web of Science ®Google Scholar
• Hossain A, Kuo MT, Saunders GF. miR-17–5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol. Cell Biol.26, 8191–8201 (2006).
   PubMed Web of Science ®Google Scholar
• Anzick SL, Kononen J, Walker RL et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science277, 965–968 (1997).
   PubMed Web of Science ®Google Scholar
• Ghadimi BM, Schrock E, Walker RL et al. Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas. Am. J. Pathol.154, 525–536 (1999).
   PubMed Web of Science ®Google Scholar
• Louie MC, Zou JX, Rabinovich A, Chen HW. ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance. Mol. Cell. Biol.24, 5157–5171 (2004).
   PubMed Web of Science ®Google Scholar
• Yu Z, Wang C, Wang M et al. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J. Cell Biol.182, 509–517 (2008).
   PubMed Web of Science ®Google Scholar
• Tavazoie SF, Alarcon C, Oskarsson T et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature451, 147–152 (2008).
   PubMed Web of Science ®Google Scholar
• Zhang J, Du YY, Lin YF et al. The cell growth suppressor, miR-126, targets IRS-1. Biochem. Biophys. Res. Commun.377, 136–140 (2008).
   PubMed Web of Science ®Google Scholar
• Adams BD, Furneaux H, White BA. The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-α (ERα) and represses ERa messenger RNA and protein expression in breast cancer cell lines. Mol. Endocrinol.21, 1132–1147 (2007).
   PubMed Web of Science ®Google Scholar
• Kondo N, Toyama T, Sugiura H, Fujii Y, Yamashita H. miR-206 expression is down-regulated in estrogen receptor α-positive human breast cancer. Cancer Res.68, 5004–5008 (2008).
   PubMed Web of Science ®Google Scholar
• Spizzo R, Nicoloso MS, Lupini L et al. miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-α in human breast cancer cells. Cell Death Differ.17(2), 246–254 (2010).
   PubMed Web of Science ®Google Scholar
• Bandres E, Cubedo E, Agirre X et al. Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol. Cancer5, 29 (2006).
   PubMed Web of Science ®Google Scholar
• Li W, Xie L, He X et al. Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. Int. J. Cancer123, 1616–1622 (2008).
   PubMed Web of Science ®Google Scholar
• Fornari F, Gramantieri L, Ferracin M et al. miR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene27, 5651–5661 (2008).
   PubMed Web of Science ®Google Scholar
• Jiang J, Gusev Y, Aderca I et al. Association of microRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, patient survival. Clin. Cancer Res.14, 419–427 (2008).
   PubMed Web of Science ®Google Scholar
• Gabriely G, Wurdinger T, Kesari S et al. microRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol. Cell Biol.28, 5369–5380 (2008).
   PubMed Web of Science ®Google Scholar
• Conti A, Aguennouz M, La Torre D et al. miR-21 and 221 upregulation and miR-181b downregulation in human grade II–IV astrocytic tumors. J. Neurooncol.93, 325–332 (2009).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chao T, Li R et al. microRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J. Mol. Med.87, 43–51 (2009).
   PubMed Web of Science ®Google Scholar
• Calin GA, Liu CG, Sevignani C et al. microRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl Acad. Sci. USA101, 11755–11760 (2004).
   PubMed Web of Science ®Google Scholar
• Calin GA, Ferracin M, Cimmino A et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med.353, 1793–1801 (2005).
   PubMed Web of Science ®Google Scholar
• Scaglione BJ, Salerno E, Balan M et al. Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model. Br. J. Haematol.139, 645–657 (2007).
   PubMed Web of Science ®Google Scholar
• Marton S, Garcia MR, Robello C et al. Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. Leukemia22, 330–338 (2008).
   PubMed Web of Science ®Google Scholar
• Venturini L, Battmer K, Castoldi M et al. Expression of the miR-17–92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood109, 4399–4405 (2007).
   PubMed Web of Science ®Google Scholar
• Bueno MJ, Perez de Castro I, Gomez de Cedron M et al. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell13, 496–506 (2008).
   PubMed Web of Science ®Google Scholar
• Agirre X, Jimenez-Velasco A, San Jose-Eneriz E et al. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth. Mol. Cancer Res.6, 1830–1840 (2008).
   PubMed Web of Science ®Google Scholar
• Zanette DL, Rivadavia F, Molfetta GA et al. miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia, Braz. J. Med. Biol. Med.40, 1435–1440 (2007).
   Web of Science ®Google Scholar
• Nagel S, Venturini L, Przybylski GK et al. Activation of miR-17–92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1 in T-cell acute lymphoblastic leukemia. Leuk. Lymph.50, 101–108 (2009).
   PubMed Web of Science ®Google Scholar
• Mi S, Lu J, Sun M et al. microRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc. Natl Acad. Sci. USA104(50), 19971–19976 (2007).
   PubMed Web of Science ®Google Scholar
• Burnett AK. Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?. – an adult treater’s view. Br. J. Haematol.118, 357–364 (2002).
   PubMed Web of Science ®Google Scholar
• Garzon R, Garofalo M, Martelli MP et al. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc. Natl Acad. Sci. USA105, 3945–3950 (2008).
   PubMed Web of Science ®Google Scholar
• Fazi F, Racanicchi S, Zardo G et al. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell12, 457–466 (2007).
   PubMed Web of Science ®Google Scholar
• Garzon R, Liu S, Fabbri M et al. microRNA -29b induces global DNA hypomethylation and tumor suppressor gene re-expression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood113(25), 6411–6418 (2009).
   PubMed Web of Science ®Google Scholar
• Fabbri M, Garzon R, Cimmino A et al. microRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl Acad. Sci. USA104, 15805–15810 (2007).
   PubMed Web of Science ®Google Scholar
• Garzon R, Heaphy CE, Havelange V et al. microRNA 29b functions in acute myeloid leukemia. Blood114(26), 5331–5341 (2009).
   PubMed Web of Science ®Google Scholar
• Eis PS, Tam W, Sun L et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl Acad. Sci. USA102, 3627–3632 (2005).
   PubMed Web of Science ®Google Scholar
• Tam W, Hughes SH, Hayward WS, Besmer P. Avian BIC, a gene isolated from a common retroviral site in avian leukosis virus-induced lymphomas that encodes a noncoding RNA, cooperates with c-myc in lymphomagenesis and erythroleukemogenesis. J. Virol.76, 4275–4286 (2002).
   PubMed Web of Science ®Google Scholar
• Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer39, 167–169 (2004).
   PubMed Web of Science ®Google Scholar
• Lawrie CH, Soneji S, Marafioti T et al. microRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int. J. Cancer121, 1156–1161 (2007).
   PubMed Web of Science ®Google Scholar
• Roehle A, Hoefig KP, Repsilber D et al. microRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. Br. J. Haematol.142(5), 732–744 (2008).
   PubMed Web of Science ®Google Scholar
• Kluiver J, Poppema S, de Jong D et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J. Pathol.207, 243–249 (2005).
   PubMed Web of Science ®Google Scholar
• Nie K, Gomez M, Landgraf P et al. microRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. Am. J. Pathol.173, 242–252 (2008).
   PubMed Web of Science ®Google Scholar
• Van Vlierberghe P, De Weer A, Mestdagh P et al. Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs. Br. J. Haematol.147, 686–690 (2009).
   PubMed Web of Science ®Google Scholar
• Costinean S, Zanesi N, Pekarsky Y et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc. Natl Acad. Sci. USA103, 7024–7029 (2006).
   PubMed Web of Science ®Google Scholar
• Costinean S, Sandhu S, Pedersen I et al. Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein β are targeted by miR-155 in B cells of Emicro-miR-155 transgenic mice. Blood114, 1374–1382 (2009).
   PubMed Web of Science ®Google Scholar
• Thai TH, Calado DP, Casola S et al. Regulation of the germinal center response by microRNA-155. Science316, 604–608 (2007).
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Vigorito E, Clare S et al. Requirement of BIC/microRNA-155 for normal immune function. Science316, 608–611 (2007).
   PubMed Web of Science ®Google Scholar
• Mendell JT. miRiad roles for the miR-17–92 cluster in development and disease. Cell133, 217–222 (2008).
   PubMed Web of Science ®Google Scholar
• He L, Thomson JM, Hemann MT et al. A microRNA polycistron as a potential human oncogene. Nature435, 828–833 (2005).
   PubMed Web of Science ®Google Scholar
• Ota A, Tagawa H, Karnan S et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res.64, 3087–3095 (2004).
   PubMed Web of Science ®Google Scholar
• Xiao C, Srinivasan L, Calado DP et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17–92 expression in lymphocytes. Nat. Immunol.9, 405–414 (2008).
   PubMed Web of Science ®Google Scholar
• Landais S, Landry S, Legault P, Rassart E. Oncogenic potential of the miR-106–363 cluster and its implication in human T-cell leukemia. Cancer Res.67, 5699–5707 (2007).
   PubMed Web of Science ®Google Scholar
• Petrocca F, Visone R, Onelli MR et al. E2F1-regulated microRNAs impair TGFβ-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell13, 272–286 (2008).
   PubMed Web of Science ®Google Scholar
• Derynck R, Akhurst RJ, Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nat. Genet29, 117–129 (2001).
   PubMed Web of Science ®Google Scholar
• Ventura A, Young AG, Winslow MM et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell132, 875–886 (2008).
   PubMed Web of Science ®Google Scholar
• Akao Y, Nakagawa Y, Kitade Y, Kinoshita T, Naoe T. Downregulation of microRNAs-143 and -145 in B-cell malignancies. Cancer Sci. (2007).
   PubMedGoogle Scholar
• Navarro A, Gaya A, Martinez A et al. microRNA expression profiling in classical Hodgkin lymphoma. Blood111(5), 2825–2832 (2008).
   PubMed Web of Science ®Google Scholar
• Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N. Engl. J. Med.352, 804–815 (2005).
   PubMed Web of Science ®Google Scholar
• Cimmino A, Calin GA, Fabbri M et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl Acad. Sci. USA102, 13944–13949 (2005).
   PubMed Web of Science ®Google Scholar
• Pekarsky Y, Santanam U, Cimmino A et al. Tcl1 expression in CLL is regulated by miR-29 and miR-181. Cancer Res.66, 11590–11593 (2006).
   PubMed Web of Science ®Google Scholar
• Stamatopoulos B, Meuleman N, Haibe-Kains B et al. microRNA-29c and microRNA-223 downregulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood113(21), 5237–5245 (2009).
   PubMed Web of Science ®Google Scholar
• Fourouclas N, Campbell PJ, Bench AJ et al. Size matters: the prognostic implications of large and small deletions of the derivative 9 chromosome in chronic myeloid leukemia. Haematologica91, 952–955 (2006).
   PubMed Web of Science ®Google Scholar
• Kreil S, Pfirrmann M, Haferlach C et al. Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemia. Blood110, 1283–1290 (2007).
   PubMed Web of Science ®Google Scholar
• Chaubey A, Karanti S, Rai D, Oh T, Adhvaryu SG, Aguiar RC. microRNAs and deletion of the derivative chromosome 9 in chronic myeloid leukemia. Leukemia23, 186–188 (2009).
   PubMed Web of Science ®Google Scholar
• Roman-Gomez J, Agirre X, Jimenez-Velasco A et al. Epigenetic regulation of microRNAs in acute lymphoblastic leukemia. J. Clin. Oncol.27, 1316–1322 (2009).
   PubMed Web of Science ®Google Scholar
• Agirre X, Vilas-Zornoza A, Jimenez-Velasco A et al. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. Cancer Res.69(10), 4443–4453 (2009).
   PubMed Web of Science ®Google Scholar
• Garzon R, Volinia S, Liu CG et al. microRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood111(6), 3183–3189 (2008).
   PubMed Web of Science ®Google Scholar
• Marcucci G, Radmacher MD, Maharry K et al. microRNA expression in cytogenetically normal acute myeloid leukemia. N. Engl. J. Med.358, 1919–1928 (2008).
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Wright G, Leroy K et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J. Exp. Med.198, 851–862 (2003).
   PubMed Web of Science ®Google Scholar
• Rai D, Karanti S, Jung I, Dahia PL, Aguiar RC. Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. Cancer Genet. Cytogenet.181, 8–15 (2008).
   PubMed Web of Science ®Google Scholar
• Navarro A, Diaz T, Martinez A et al. Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma. Blood114, 2945–2951 (2009).
   PubMed Web of Science ®Google Scholar